Henry Schein Inc. the exclusive U.S. distributor of CAMLOG Biotechnologies Implant Systems has created a new glossy, catalog – nearly 100 pages of detailed product offerings for one of the fastest growing dental implant systems
.
Based on 30 years of implant dentistry experience, the CAMLOG Implant System was developed to overcome conventional implants’ handling problems, as well as esthetic and functional limitations. The CAMLOG System combines stability, precision engineering, and superior prosthetics with system simplicity. It was designed for all requirements and offers patient flexibility in prosthetic decisions. The CAMLOG Implant system is easy to learn and use, and provide excellent restorative and esthetic results.
The new 88-page CAMLOG catalog features an overview of the CAMLOG System’s benefits and is divided into three distinct product sections:
The first section, Surgery, features the CAMLOG Screw Line (screw implants) CAMLOG Root –Line (screw implants root form), CAMLOG Cylinder-Line (cylinder implants) and CAMLOG Screw-Cylinder-Line (screw cylinder) implants as well as surgical instruments, sets and drills.
The Prosthetic Section details the CAMLOG prosthetic range, instruments and parts for implants 3.3mm-6.0 mm. The third section focuses on Supplementary products including practice implants and abutments, osteotomy sets, sinus floor elevation instruments and educational materials. A comprehensive Index follows at the end with a convenient order form. To request a copy of the CAMLOG Biotechnologies catalog, call 877-537-8862.
The Sullivan Schein Dental division of Henry Schein signed an exclusive distribution agreement for the CAMLOG System in 2004. “We are highly committed to the growth and broad acceptance of the CAMLOG system in the U.S.,” says Angela Mancuso, Camlog’s Director of Sales. “Already, doctors using the system are recognizing CAMLOG’s flexibility for any implant indication, predictable results and ease of use over other implant systems.”
In 2003, more than 700,000 dental implant procedures were estimated to have been performed by oral surgeons and other dental professionals in the United States and more than 1.3 million procedures in Europe.
The current market for dental implants is estimated to be more than $1 billion globally and over $400 million in the United States, with the category expected to grow at 10 to 15 percent annually. In 2003, more than 700,000 dental implant procedures were estimated to have been performed by oral surgeons and other dental professionals in the United States and more than 1.3 million procedures in Europe.
An aging population with increasing wealth should drive dental implant surgery in the future. Over the next 10 years, the number of people age 50 and above in developed countries is expected to increase by over 60 million, to a total of 452 million. This segment also will be spurred by the enhancement of implant technologies, including accelerated healing times and more refined implant designs. Additionally, increasing patient awareness of implant solutions, the procedure's success rate, and increasing simplicity of treatment should drive growth.